Benign and hyperplastic endometrial changes associated with tamoxifen use

ONCOLOGY

Volumn 11, Issue 2 SUPPL. 1, 1997, Pages 35-37

  Barakat, Richard R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

BREAST CANCER; CONFERENCE PAPER; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; POLYP; RISK FACTOR; SCREENING;

CLINICAL TRIALS; COSTS AND COST ANALYSIS; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; MASS SCREENING; TAMOXIFEN;

EID: 0030939785     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (9)

1. Lahti E, Blanco G, Kauppila A, et al: Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 81:660-664, 1993.
2. Corley D, Rowe J, Curtis MT, et al: Postmenopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy. Obstet Gynecol 79:111-116, 1992
3. Gal D, Kopel S, Bashevkin M, et al: Oncologic potential of tamoxifen on endometria of postmenopausal women with breast cancer: Preliminary report. Gynecol Oncol 42:120-123, 1991.
4. Gibson LE, Barakat RR, Venkatraman ES, et al: Endometrial pathology at dilatation and curettage in breast cancer patients: Comparison of tamoxifen users and nonusers. Cancer J Sci Am 2-35-38, 1995.
5. Kedar RP, Bourne TH, Powles TJ, et al: Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial Lancet 343:1318-1321, 1994.
6. Barakat RR, Gilewski TA, Saigo PE, et al: The effect of adjuvant tamoxifen on the endometrium in women with breast cancer: an interim analysis of a prospective study [abstract]. Proc Am Soc Clin Oncol 779, 1995.
7. Assikis VJ and Jordan VC: Gynecologic effects of tamoxifen and the association with endometrial carcinoma. Int J Gynecol Obstet 49:241-257, 1995.
8. Cohen I, Tepper R, Rosen DJD, et al: Continuous tamoxifen treatment in asymptomatic postmenopausal breast cancer patients does not cause aggravation of endometrial pathologies. Gynecol Oncol 55:138-143, 1994.
9. Decensi A, Fontana V, Bruno S, et al: Effect of tamoxifen on endometrial proliferation. J Clin Oncol 14:434-440, 1996.